Annual Current Liabilities
$89.22 M
+$13.54 M+17.89%
December 31, 2023
Summary
- As of February 7, 2025, RVNC annual total current liabilities is $89.22 million, with the most recent change of +$13.54 million (+17.89%) on December 31, 2023.
- During the last 3 years, RVNC annual current liabilities has risen by +$28.26 million (+46.36%).
- RVNC annual current liabilities is now -24.34% below its all-time high of $117.94 million, reached on December 31, 2012.
Performance
RVNC Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$80.05 M
-$13.58 M-14.51%
September 30, 2024
Summary
- As of February 7, 2025, RVNC quarterly total current liabilities is $80.05 million, with the most recent change of -$13.58 million (-14.51%) on September 30, 2024.
- Over the past year, RVNC quarterly current liabilities has dropped by -$2.11 million (-2.57%).
- RVNC quarterly current liabilities is now -32.12% below its all-time high of $117.94 million, reached on December 31, 2012.
Performance
RVNC Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
RVNC Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +17.9% | -2.6% |
| 3 y3 years | +46.4% | +21.5% |
| 5 y5 years | +179.1% | +134.4% |
RVNC Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +32.6% | -14.5% | +19.0% |
| 5 y | 5-year | at high | +117.7% | -14.5% | +95.3% |
| alltime | all time | -24.3% | +907.6% | -32.1% | +1145.5% |
Revance Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $80.05 M(-14.5%) |
| Jun 2024 | - | $93.63 M(+35.9%) |
| Mar 2024 | - | $68.90 M(-22.8%) |
| Dec 2023 | $89.22 M(+17.9%) | $89.22 M(+8.6%) |
| Sep 2023 | - | $82.16 M(+10.9%) |
| Jun 2023 | - | $74.08 M(-5.0%) |
| Mar 2023 | - | $77.98 M(+3.0%) |
| Dec 2022 | $75.68 M(+12.5%) | $75.68 M(+1.3%) |
| Sep 2022 | - | $74.73 M(-3.2%) |
| Jun 2022 | - | $77.23 M(+8.7%) |
| Mar 2022 | - | $71.07 M(+5.6%) |
| Dec 2021 | $67.29 M(+10.4%) | $67.29 M(+2.1%) |
| Sep 2021 | - | $65.87 M(+13.1%) |
| Jun 2021 | - | $58.25 M(+14.6%) |
| Mar 2021 | - | $50.84 M(-16.6%) |
| Dec 2020 | $60.96 M(+48.8%) | $60.96 M(-4.2%) |
| Sep 2020 | - | $63.65 M(+32.6%) |
| Jun 2020 | - | $47.99 M(+15.3%) |
| Mar 2020 | - | $41.63 M(+1.6%) |
| Dec 2019 | $40.98 M(+28.2%) | $40.98 M(+20.0%) |
| Sep 2019 | - | $34.15 M(-23.6%) |
| Jun 2019 | - | $44.70 M(+31.2%) |
| Mar 2019 | - | $34.07 M(+6.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $31.97 M(+53.0%) | $31.97 M(+0.5%) |
| Sep 2018 | - | $31.81 M(+12.3%) |
| Jun 2018 | - | $28.32 M(+23.2%) |
| Mar 2018 | - | $23.00 M(+10.0%) |
| Dec 2017 | $20.90 M(+6.4%) | $20.90 M(-2.7%) |
| Sep 2017 | - | $21.48 M(-2.3%) |
| Jun 2017 | - | $21.98 M(-8.6%) |
| Mar 2017 | - | $24.04 M(+22.4%) |
| Dec 2016 | $19.65 M(+63.2%) | $19.65 M(+12.2%) |
| Sep 2016 | - | $17.52 M(+47.0%) |
| Jun 2016 | - | $11.92 M(-4.6%) |
| Mar 2016 | - | $12.49 M(+3.7%) |
| Dec 2015 | $12.04 M(+17.6%) | $12.04 M(+2.5%) |
| Sep 2015 | - | $11.74 M(+15.6%) |
| Jun 2015 | - | $10.16 M(+58.0%) |
| Mar 2015 | - | $6.43 M(-37.2%) |
| Dec 2014 | $10.24 M(-78.5%) | $10.24 M(-30.6%) |
| Sep 2014 | - | $14.75 M(-21.4%) |
| Jun 2014 | - | $18.77 M(-17.0%) |
| Mar 2014 | - | $22.61 M(-52.5%) |
| Dec 2013 | $47.56 M(-59.7%) | $47.56 M(+50.2%) |
| Sep 2013 | - | $31.68 M(-73.1%) |
| Dec 2012 | $117.94 M(+1231.8%) | $117.94 M |
| Dec 2011 | $8.86 M | - |
FAQ
- What is Revance Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Revance Therapeutics?
- What is Revance Therapeutics annual current liabilities year-on-year change?
- What is Revance Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Revance Therapeutics?
- What is Revance Therapeutics quarterly current liabilities year-on-year change?
What is Revance Therapeutics annual total current liabilities?
The current annual current liabilities of RVNC is $89.22 M
What is the all time high annual current liabilities for Revance Therapeutics?
Revance Therapeutics all-time high annual total current liabilities is $117.94 M
What is Revance Therapeutics annual current liabilities year-on-year change?
Over the past year, RVNC annual total current liabilities has changed by +$13.54 M (+17.89%)
What is Revance Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of RVNC is $80.05 M
What is the all time high quarterly current liabilities for Revance Therapeutics?
Revance Therapeutics all-time high quarterly total current liabilities is $117.94 M
What is Revance Therapeutics quarterly current liabilities year-on-year change?
Over the past year, RVNC quarterly total current liabilities has changed by -$2.11 M (-2.57%)